CHINA GLASS (03300) has entered into a second amended and restated contract with all parties.
China Glass (03300) announces that as of November 13, 2025, the Group has entered into the second...
CHINA GLASS (03300) announced that as of November 13, 2025, the Group has entered into a second amended and restated agreement (2025 Agreement) with various parties to amend and restate the financing agreement, changing the repayment date to one year from the effective date of the 2025 Agreement (November 13, 2025), with the option to extend the period for up to six months subject to certain conditions.
Related Articles

Shareholders Xinkang Cheng and Xincheng Longcheng of Pharmaron Beijing (03759) plan to jointly reduce their shareholding by approximately 26.67 million shares.

CHANJET (01588) spent HK$32,700 to repurchase 3800 shares on November 14th.

LING YUI (00784) announced its interim results, with a net profit of HK$311,000, a decrease of 79.88% year-on-year.
Shareholders Xinkang Cheng and Xincheng Longcheng of Pharmaron Beijing (03759) plan to jointly reduce their shareholding by approximately 26.67 million shares.

CHANJET (01588) spent HK$32,700 to repurchase 3800 shares on November 14th.

LING YUI (00784) announced its interim results, with a net profit of HK$311,000, a decrease of 79.88% year-on-year.

RECOMMEND

Energy Storage Industry Set To Ride the AI Tailwind; UBS: Global Demand May Surge 40% Next Year
13/11/2025

Double Eleven’s Cooling To A Historic Low? A Necessary Step Toward E‑commerce Maturity
13/11/2025

On The Eve of L3 Mass Commercialization: How Autonomous Driving Will Reconfigure a Trillion‑Yuan Service Market
13/11/2025


